Engaging Mobile Prism Adaptation Treatment at Home
Launched by NOVA SCOTIA HEALTH AUTHORITY · Oct 22, 2022
Trial Information
Current as of May 15, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment for spatial neglect, a condition that can occur after a stroke, where individuals have difficulty noticing or responding to things on one side, often the left side. This can make everyday activities like eating, dressing, and moving around more challenging. The researchers are testing a game-like treatment called Peg-the-Mole, which uses a special device that patients can use at home without needing a therapist to set it up each day. The goal is to see if this treatment can help improve symptoms of neglect.
To participate in the trial, individuals must have had a stroke on the right side of the brain and have mild to severe neglect symptoms. They should also be medically stable and able to give consent to join the study. Participants will be able to use the treatment in both a hospital setting and at home. It’s important to note that the trial is currently active but not recruiting new participants. If you or someone you know is interested in learning more, it’s best to consult with a healthcare provider for guidance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Have experienced a right hemisphere stroke (confirmed by a clinician)
- • 2. Experience mild to severe symptoms of neglect
- • 3. Be willing and able to consent to participate
- • 4. Be medically stable
- • 5. Have self-reported normal to corrected-to-normal vision
- • 6. Be able to point to targets presented on a computer screen
- • 7. Live within a two-hour radius of Halifax
- Exclusion Criteria:
- • Other existing neurological disorders (e.g., dementia, multiple sclerosis, epilepsy).
About Nova Scotia Health Authority
The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials